EOLS logo

EOLS

Evolus Inc.

$7.04
+$0.13(+1.88%)
57
Overall
40
Value
60
Tech
71
Quality
Market Cap
$452.44M
Volume
644.90K
52W Range
$5.71 - $17.12
Target Price
$19.40

Company Overview

Mkt Cap$452.44MPrice$7.04
Volume644.90KChange+1.88%
P/E Ratio-9.0Open$6.90
Revenue$266.3MPrev Close$6.91
Net Income$-50.4M52W Range$5.71 - $17.12
Div YieldN/ATarget$19.40
Overall57Value40
Quality71Technical60

No chart data available

About Evolus Inc.

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Latest News

Mizuho Securities Keeps Their Buy Rating on Evolus (EOLS)

In a report released today, Uy Ear from Mizuho Securities maintained a Buy rating on Evolus, with a price target of $19.00. According to TipRanks, ...

TipRanks Auto-Generated Intelligence Newsdesk3 days ago

Analysts Are Bullish on Top Healthcare Stocks: Evolus (EOLS), Inotiv (NOTV)

Catie Powers12 days ago
ABCD
1SymbolPriceChangeVol
2EOLS$7.04+1.9%644.90K
3
4
5
6

Get Evolus Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.